Table II.

Formulations Prepared for In Vivo (M-)TCI Study

DT dose (μg)	Adjuvants	Adjuvant dose (μg)	Solvent (pH)	Volume (μl)
for s.c. injection
5	AlPO4	150	0.9% saline (7.0)	100
5	–	–	0.9% saline (7.0)	100
(M)-TCI
100	–	–	PBSa (7.4)	70
100	lpxL1 LPS	25	PBS/Trisb (7.4)	70
100	Quil A	100	PBS (7.4)	70
100	CT	100	PBS (7.4)	70
100	CpG	100	PBS (7.4)	70
100	AlPO4	3,000	0.9% saline (7.0)	70

^aPBS: 2.67 mM KCl, 1.47 mM KH₂PO₄, 137.93 mM NaCl, 8.06 mM Na₂HPO₄·7H₂O, without Ca^2 + and Mg²⁺

^bPBS/Tris: PBS mixed with 1 mM Tris–HCl (v/v = 5:3).